Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
52.6M
-
Shares change
-
-4.65M
-
Total reported value, excl. options
-
$86.7M
-
Value change
-
-$23.3M
-
Put/Call ratio
-
0
-
Number of buys
-
49
-
Number of sells
-
-33
-
Price
-
$1.65
Significant Holders of Generation Bio Co. - #OTHER (GBIO) as of Q4 2023
95 filings reported holding GBIO - Generation Bio Co. - #OTHER as of Q4 2023.
Generation Bio Co. - #OTHER (GBIO) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.6M shares
of 67M outstanding shares and own 78.44% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (8.28M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.93M shares), FMR LLC (5.35M shares), Bellevue Group AG (3.62M shares), BlackRock Inc. (3.17M shares), Artal Group S.A. (2.81M shares), VANGUARD GROUP INC (2.55M shares), BANK OF AMERICA CORP /DE/ (2.53M shares), EcoR1 Capital, LLC (2.05M shares), and PFM Health Sciences, LP (1.62M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.